Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages (Q56794691)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 September 2006

Language	Label	Description	Also known as
English	Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages	scientific article published on 25 September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Christopher Destache

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Howard E. Gendelman

11

object named as

Howard E Gendelman

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Huanyu Dou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Justin Morehead

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Lyudmila Shlyakhtenko

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

You Zhou

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mahesh Chaubal

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jane Werling

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

James Kipp

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jeffrey D Kingsley

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Barrett E Rabinow

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

0 references

publication date

25 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

number of pages

11

1 reference

based on heuristic

inferred from page(s)

0 references

358

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

148-158

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

New approaches to the delivery of drugs to the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

PLGA nanoparticles in drug delivery: the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Macrophage specific drug delivery in experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Protein binding in antiretroviral therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Bionanotechnology progress and advances

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Immunologic and Virologic Consequences of Temporary Antiretroviral Treatment Interruption in Clinical Practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

The neuropathogenesis of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Smaller sized particles are preferentially taken up by alveolar type II pneumocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Role of nanobiotechnology in developing personalized medicine for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

The role of nanobiotechnology in drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Self-assembled drug delivery systems. 1. Properties and in vitro/in vivo behavior of acyclovir self-assembled nanoparticles (SAN).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Microorganisms and their interaction with the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Long-term expression, systemic delivery, and macrophage uptake of recombinant human glucocerebrosidase in mice transplanted with genetically modified primary myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

HIV penetration of the BBB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Transendothelial migration of monocytes: the underlying molecular mechanisms and consequences of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Effects of colony stimulating factors on the interaction of monocytes and the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Novel arylsulfonamides possessing sub-picomolar HIV protease activities and potent anti-HIV activity against wild-type and drug-resistant viral strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Liposome-mediated delivery of gallium to macrophage-like cells in vitro: demonstration of a transferrin-independent route for intracellular delivery of metal ions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Determining and overcoming resistance to HIV protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Macrophage protection against human immunodeficiency virus or herpes simplex virus by red blood cell-mediated delivery of a heterodinucleotide of azidothymidine and acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Para-acyl calix[4]arenes: amphiphilic self-assembly from the molecular to the mesoscopic level

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Antiretroviral compounds: mechanisms underlying failure of HAART to eradicate HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Effect of physiological media on the stability of surface-adsorbed DNA-dendron-gold nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

The role of microglia and macrophages in the pathophysiology of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Anti-HIV drug distribution to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Alginate in drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Macrophages and HIV-1: dangerous liaisons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Cellular mechanisms of feline immunodeficiency virus FIV -induced neuropathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.08.012

7 January 2021

Identifiers

10.1016/J.VIROL.2006.08.012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16997345%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56794691&oldid=2214162506"